Association of MHC class II-peptide complexes with plasma membrane lipid microdomains

Current Opinion in Immunology

Volumn 16, Issue 1, 2004, Pages 103-107

  Poloso, Neil J ^a   Roche, Paul A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE LIPID; PEPTIDE; TETRASPANIN;

ANTIGEN FUNCTION; ANTIGEN PRESENTING CELL; ASSOCIATION; CELL MEMBRANE; CELL TYPE; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); IMMUNE SYSTEM; MOLECULE; PROTEIN LOCALIZATION; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 1042286458     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2003.11.009     Document Type: Review

References (44)

1. Hunt D.F., Michel H., Dickinson T.A., Shabanowitz J., Cox A.L., Sakaguchi K., Appella E., Grey H.M., Sette A. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. Science. 256:1992;1817-1820.
2. Demotz S., Grey H.M., Sette A. The minimal number of class II MHC-antigen complexes needed for T cell activation. Science. 249:1990;1028-1030.
3. Harding C.V., Unanue E.R. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature. 346:1990;574-576.
4. Reay P.A., Matsui K., Haase K., Wülfing C., Chien Y.H., Davis M.M. Determination of the relationship between T cell responsiveness and the number of MHC-peptide complexes using specific monoclonal antibodies. J. Immunol. 164:2000;5626-5634.
5. Irvine D.J., Purbhoo M.A., Krogsgaard M., Davis M.M. Direct observation of ligand recognition by T cells. Nature. 419:2002;845-849.
6. Jenei A., Varga S., Bene L., Matyus L., Bodnar A., Bacso Z., Pieri C., Gaspar R. Jr., Farkas T., Damjanovich S. HLA class I and II antigens are partially co-clustered in the plasma membrane of human lymphoblastoid cells. Proc. Natl. Acad. Sci. USA. 94:1997;7269-7274.
7. Vereb G., Matko J., Vamosi G., Ibrahim S.M., Magyar E., Varga S., Szollosi J., Jenei A., Gaspar R. Jr., Waldmann T.A.et al. Cholesterol-dependent clustering of IL-2Ralpha and its colocalization with HLA and CD48 on T lymphoma cells suggest their functional association with lipid rafts. Proc. Natl. Acad. Sci. USA. 97:2000;6013-6018.
8. Maxfield F.R. Plasma membrane microdomains. Curr. Opin. Cell. Biol. 14:2002;483-487.
9. Pizzo P., Giurisato E., Tassi M., Benedetti A., Pozzan T., Viola A. Lipid rafts and T cell receptor signaling: a critical re-evaluation. Eur. J. Immunol. 32:2002;3082-3091.
10. Edidin M. The state of lipid rafts: from model membranes to cells. Annu. Rev. Biophys. Biomol. Struct. 32:2003;257-283 This is a particularly interesting review of lipid rafts that includes an important historical perspective of membrane microdomains and summarizes biophysical data of lipid rafts in model membranes and intact cells.
11. Simons K., Ikonen E. Functional rafts in cell membranes. Nature. 387:1997;569-572.
12. Brown D.A., London E. Functions of lipid rafts in biological membranes. Annu. Rev. Cell. Dev. Biol. 14:1998;111-136.
13. Lai E.C. Lipid rafts make for slippery platforms. J. Cell. Biol. 162:2003;365-370.
14. Anderson R.G., Jacobson K. A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science. 296:2002;1821-1825.
15. Huby R.D., Dearman R.J., Kimber I. Intracellular phosphotyrosine induction by major histocompatibility complex class II requires co-aggregation with membrane rafts. J. Biol. Chem. 274:1999;22591-22596.
16. Anderson H.A., Hiltbold E.M., Roche P.A. Concentration of MHC class II molecules in lipid rafts facilitates antigen presentation. Nat. Immunol. 1:2000;156-162.
17. Bouillon M., El Fakhry Y., Girouard J., Khalil H., Thibodeau J., Mourad W. Lipid raft-dependent and -independent signaling through HLA-DR molecules. J. Biol. Chem. 278:2003;7099-7107 These investigators found constitutive association of MHC-II with lipid rafts in tonsil B cells, transformed B cells and human monocytes. This is the first demonstration of class II association with lipid rafts from primary cells.
18. Setterblad N., Roucard C., Bocaccio C., Abastado J.P., Charron D., Mooney N. Composition of MHC class II-enriched lipid microdomains is modified during maturation of primary dendritic cells. J. Leukoc. Biol. 74:2003;40-48 This study shows that approximately 15% of plasma membrane MHC-II is present in lipid raft microdomains in immature human DCs. Surprisingly, despite increases in total surface MHC-II, DC maturation seems to inhibit surface MHC-II association with rafts.
19. Hiltbold E.M., Poloso N.J., Roche P.A. MHC class II-peptide complexes and APC lipid rafts accumulate at the immunological synapse. J. Immunol. 170:2003;1329-1338 This study makes use of a mAb that recognizes a specific pMHC-II complex to examine the recruitment and distribution of both immunologically relevant and irrelevant MHC-II at the immune synapse. Under conditions of limiting antigen dose, relevant pMHC-II complex, B-cell lipid rafts and even small amounts of irrelevant MHC-II are recruited to the immunological synapse. Co-patching studies using pMHC-II-specific mAb suggest that recruitment is mediated by the association of relevant and irrelevant MHC-II with lipid rafts, providing a potential role for rafts in recruiting un-engaged class II molecules to the T-cell-APC contact site.
20. Setterblad N., Bécart S., Charron D., Mooney N. Signalling via MHC class II molecules modifies the composition of GEMs in APC. Scand. J. Immunol. 54:2001;87-92.
21. Goebel J., Forrest K., Flynn D., Rao R., Roszman T.L. Lipid rafts, major histocompatibility complex molecules, and immune regulation. Hum. Immunol. 63:2002;813-820.
22. De Gassart A, Geminard C, Fevrier B, Raposo G, Vidal M: Lipid raft-associated proteins are sorted in exosomes. Blood 2003 (published online July 2003). DOI: 10.1182/blood-2003-03-0871.
23. •]) find that neither the constitutive nor mAb-induced association of MHC-II with lipid rafts is dependent on the MHC-II α- or β-chain cytosolic domains. However, these authors find that these MHC-II mutants do not signal properly, thereby discriminating motifs responsible for MHC-II signaling and raft association.
24. Harder T., Scheiffele P., Verkade P., Simons K. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J. Cell. Biol. 141:1998;929-942.
25. Janes P.W., Ley S.C., Magee A.I. Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor. J. Cell. Biol. 147:1999;447-461.
26. Miura Y., Hanada K., Jones T.L. G(s) signaling is intact after disruption of lipid rafts. Biochemistry. 40:2001;15418-15423.
27. Kropshofer H., Spindeldreher S., Rohn T.A., Platania N., Grygar C., Daniel N., Wolpl A., Langen H., Horejsi V., Vogt A.B. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes. Nat. Immunol. 3:2002;61-68 This study investigates the association of MHC-II, HLA-DM and B7.2 with proteins of the tetraspanin web. They find tetraspanin-associated MHC-II molecules possess a unique, limited peptide repertoire in comparison to the bulk of MHC-II or raft-associated MHC-II. Using a mAb that reportedly associates with tetraspanin-associated MHC-II they show increased surface expression of these complexes during DC maturation, suggesting an important role for tetraspanin web associations in MHC-II-dependent T-cell activation.
28. Pralle A., Keller P., Florin E.L., Simons K., Horber J.K. Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells. J. Cell. Biol. 148:2000;997-1008.
29. Haque M.A., Hawes J.W., Blum J.S. Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition. J. Immunol. 166:2001;4543-4551.
30. Turley S.J., Inaba K., Garrett W.S., Ebersold M., Unternaehrer J., Steinman R.M., Mellman I. Transport of peptide-MHC class II complexes in developing dendritic cells. Science. 288:2000;522-527.
31. Machy P., Serre K., Baillet M., Leserman L. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains. J. Immunol. 168:2002;1172-1180.
32. Chow A., Toomre D., Garrett W., Mellman I. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature. 418:2002;988-994 Using DCs expressing green fluorescent protein (GFP)-MHC-II, these authors found that induction of DC maturation lead to the movement of GFP-MHC-II from lysosome-like antigen processing compartments to the plasma membrane of maturing DCs along tubulo-vesicular structures. These structures went on to fuse with the plasma membrane, thereby revealing a pathway for surface expression of MHC-II in developing DCs.
33. ••], this study examines MHC-II trafficking in DCs. The authors find that, upon contact with antigen-specific T cells, internal GFP-MHC-II traffics, via tubules, towards the T cell-DC contact site.
34. Dustin M.L., Colman D.R. Neural and immunological synaptic relations. Science. 298:2002;785-789.
35. ••], these investigators found that concentration of even non-agonist pMHC-II complexes to the contact site was agonist antigen-dose dependent. This study suggests that low-affinity non-agonist pMHC-II complexes can contribute to T-cell activation by agonist pMHC-II complexes.
36. Balamuth F., Leitenberg D., Unternaehrer J., Mellman I., Bottomly K. Distinct patterns of membrane microdomain partitioning in Th1 and th2 cells. Immunity. 15:2001;729-738.
37. Burack W.R., Lee K.H., Holdorf A.D., Dustin M.L., Shaw A.S. Cutting edge: quantitative imaging of raft accumulation in the immunological synapse. J. Immunol. 169:2002;2837-2841.
38. Bi K., Tanaka Y., Coudronniere N., Sugie K., Hong S., van Stipdonk M.J., Altman A. Antigen-induced translocation of PKC-theta to membrane rafts is required for T cell activation. Nat. Immunol. 2:2001;556-563.
39. Szollosi J., Horejsi V., Bene L., Angelisova P., Damjanovich S. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J. Immunol. 157:1996;2939-2946.
40. Vogt A.B., Spindeldreher S., Kropshofer H. Clustering of MHC-peptide complexes prior to their engagement in the immunological synapse: lipid raft and tetraspan microdomains. Immunol. Rev. 189:2002;136-151.
41. Claas C., Stipp C.S., Hemler M.E. Evaluation of prototype transmembrane 4 superfamily protein complexes and their relation to lipid rafts. J. Biol. Chem. 276:2001;7974-7984.
42. Charrin S., Manie S., Oualid M., Billard M., Boucheix C., Rubinstein E. Differential stability of tetraspanin/tetraspanin interactions: role of palmitoylation. FEBS Lett. 516:2002;139-144.
43. Berditchevski F., Odintsova E., Sawada S., Gilbert E. Expression of the palmitoylation-deficient CD151 weakens the association of alpha 3 beta 1 integrin with the tetraspanin-enriched microdomains and affects integrin-dependent signaling. J. Biol. Chem. 277:2002;36991-37000.
44. Hiltbold E.M., Roche P.A. Trafficking of MHC class II molecules in the late secretory pathway. Curr. Opin. Immunol. 14:2002;30-35.